Business Description
Aroa Biosurgery Ltd
ISIN : NZARXE0001S1
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.07 | |||||
Equity-to-Asset | 0.86 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | -1.56 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 7.05 | |||||
Beneish M-Score | -2.79 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 39.3 | |||||
3-Year EBITDA Growth Rate | 33.4 | |||||
3-Year EPS without NRI Growth Rate | 22 | |||||
3-Year FCF Growth Rate | -23.9 | |||||
3-Year Book Growth Rate | 12.2 | |||||
Future 3-5Y Total Revenue Growth Rate | 21.87 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 72.67 | |||||
9-Day RSI | 59.83 | |||||
14-Day RSI | 53.75 | |||||
6-1 Month Momentum % | -29.17 | |||||
12-1 Month Momentum % | -45.74 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 7.26 | |||||
Quick Ratio | 6.4 | |||||
Cash Ratio | 3.18 | |||||
Days Inventory | 242.15 | |||||
Days Sales Outstanding | 73.5 | |||||
Days Payable | 80.18 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.6 | |||||
Shareholder Yield % | -0.57 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 85.39 | |||||
Operating Margin % | -24.22 | |||||
Net Margin % | -15.39 | |||||
FCF Margin % | -20.79 | |||||
ROE % | -10.73 | |||||
ROA % | -9.27 | |||||
ROIC % | -23.14 | |||||
ROC (Joel Greenblatt) % | -18.7 | |||||
ROCE % | -8.67 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 555.56 | |||||
PS Ratio | 2.82 | |||||
PB Ratio | 2.06 | |||||
Price-to-Tangible-Book | 2.6 | |||||
EV-to-EBIT | -18.82 | |||||
EV-to-Forward-EBIT | -73.6 | |||||
EV-to-EBITDA | -36.16 | |||||
EV-to-Forward-EBITDA | 67.47 | |||||
EV-to-Revenue | 2.49 | |||||
EV-to-Forward-Revenue | 1.89 | |||||
EV-to-FCF | -11.22 | |||||
Price-to-Net-Current-Asset-Value | 3.71 | |||||
Price-to-Net-Cash | 13 | |||||
Earnings Yield (Greenblatt) % | -5.32 | |||||
FCF Yield % | -7.36 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Aroa Biosurgery Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | 63.357 | ||
EPS (TTM) (A$) | -0.028 | ||
Beta | 1.57 | ||
Volatility % | 33.69 | ||
14-Day RSI | 53.75 | ||
14-Day ATR (A$) | 0.020657 | ||
20-Day SMA (A$) | 0.507 | ||
12-1 Month Momentum % | -45.74 | ||
52-Week Range (A$) | 0.475 - 1.015 | ||
Shares Outstanding (Mil) | 344.21 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Aroa Biosurgery Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Aroa Biosurgery Ltd Stock Events
Event | Date | Price(A$) | ||
---|---|---|---|---|
No Event Data |
Aroa Biosurgery Ltd Frequently Asked Questions
What is Aroa Biosurgery Ltd(ASX:ARX)'s stock price today?
When is next earnings date of Aroa Biosurgery Ltd(ASX:ARX)?
Does Aroa Biosurgery Ltd(ASX:ARX) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |